Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma
Crossref DOI link: https://doi.org/10.1007/s00280-015-2774-z
Published Online: 2015-05-23
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Yi Rang
Lee, Jae Lyun
You, Dalsan
Jeong, In Gab
Song, Cheryn
Hong, Bumsik
Hong, Jun Hyuk
Ahn, Hanjong
Text and Data Mining valid from 2015-05-23